These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 1802275

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The biology of erythropoietin.
    Goldwasser E.
    Blood Purif; 1991; 9(3):119-22. PubMed ID: 1666292
    [No Abstract] [Full Text] [Related]

  • 23. [Variability of the response to recombinant human erythropoietin in patients undergoing hemodialysis treatment].
    Baroni A, Airoldi G, Agliata S, Fortina F, Ragazzoni E, Cavagnino A, De Nigris A, Cametti G, Ferrero D, Fortina A.
    Minerva Urol Nefrol; 1991; 43(3):131-5. PubMed ID: 1817334
    [Abstract] [Full Text] [Related]

  • 24. Erythropoietin: its role in the regulation of erythropoiesis and as a therapeutic in humans.
    Adamson JW.
    Biotechnology; 1991; 19():351-63. PubMed ID: 1786475
    [Abstract] [Full Text] [Related]

  • 25. Hematopoietic growth factors in pediatrics.
    Frenck RW, Shannon KM.
    Curr Opin Pediatr; 1993 Feb; 5(1):94-102. PubMed ID: 7690636
    [Abstract] [Full Text] [Related]

  • 26. Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response.
    Vadhan-Raj S, Broxmeyer HE, Hittelman WN.
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):4-13. PubMed ID: 1492234
    [No Abstract] [Full Text] [Related]

  • 27. The use of recombinant human erythropoietin (rHuEpo) in humans.
    Adamson JW, Eschbach JW.
    Cancer Surv; 1990 Oct; 9(1):157-67. PubMed ID: 2276112
    [Abstract] [Full Text] [Related]

  • 28. [Clinical applications of erythropoietin].
    Robak T.
    Acta Haematol Pol; 1994 Oct; 25(2 Suppl 1):112-23. PubMed ID: 8067196
    [Abstract] [Full Text] [Related]

  • 29. The clinical applications of colony-stimulating factors in acquired immunodeficiency syndrome.
    Scadden DT.
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):33-7. PubMed ID: 1492232
    [No Abstract] [Full Text] [Related]

  • 30. Anaphylactic shock due to recombinant human interleukin-3.
    Mittelman M, Zeidman A, Fradin Z, Menachem Y.
    Eur J Haematol; 1999 Mar; 62(3):199-200. PubMed ID: 10089898
    [No Abstract] [Full Text] [Related]

  • 31. Recombinant growth factors.
    Goodnough LT, Anderson KC.
    Transfus Sci; 1995 Mar; 16(1):45-62. PubMed ID: 10155704
    [Abstract] [Full Text] [Related]

  • 32. The use of recombinant human erythropoietin [rHuEpo] in man.
    Adamson JW, Eschbach JW.
    Prog Clin Biol Res; 1990 Mar; 352():505-17. PubMed ID: 2205875
    [No Abstract] [Full Text] [Related]

  • 33. [Treatment of neutropenia in HIV infection with hematopoietic growth factors].
    Moreno García M, Fernández González F.
    Rev Clin Esp; 1996 Apr; 196(4):248-54. PubMed ID: 8701065
    [No Abstract] [Full Text] [Related]

  • 34. Hemopoietins in clinical oncology.
    Kanz L, Lindemann A, Oster W, Herrmann F, Mertelsmann R.
    Am J Clin Oncol; 1991 Apr; 14 Suppl 1():S27-33. PubMed ID: 2048561
    [Abstract] [Full Text] [Related]

  • 35. [Current treatment methods in myelodysplastic syndromes].
    Klimenko VI, Liubarets TF.
    Lik Sprava; 1996 Apr; (10-12):20-6. PubMed ID: 9138806
    [Abstract] [Full Text] [Related]

  • 36. Clinical applications of hematopoietic growth factors.
    Vose JM, Armitage JO.
    J Clin Oncol; 1995 Apr; 13(4):1023-35. PubMed ID: 7535842
    [Abstract] [Full Text] [Related]

  • 37. Erythropoietin: physiologic basis for clinical applications.
    Schuster SJ, Caro J.
    Vox Sang; 1993 Apr; 65(3):169-79. PubMed ID: 8249358
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.